It's never just about the laboratory, it's always about the patient
We are pleased to announce the release of our 5-year strategy! Read it here
In February 2026, Dr. Kathleen Freeman wrote an essay for the Westgard QC website based on a review of the recent HbA1c issue in the NHS. A copy of her original article can be found here.
PFLM have written a response giving an update on what has happened since the initial incident and publication of the Meeting Report and Recommendations. A copy of the response can be found here.
We are extremely grateful for all the positive feedback and work that has been done so far. Remember, patient safety is at the centre for all who work in healthcare and this should always be the number one priority. It is never about the laboratory it is always about the patient.
Getting it Right for the Patient: What is Happening with POCT including DTCT (Direct-To-Consumer-Testing)
Join us for our highly requested webinar on POCT and Direct-To-Consumer-Testing.
3 CPD Credits Available
(The Royal College of Pathologists)
This webinar will be on Zoom and is free to attend. This event is aimed at everyone working in the laboratory. Though it is focused on POCT and DTCT general concepts of getting it right for the patient will be discussed so all are welcome. Everyone is welcome to attend, but you must register individually. We will be recording the sessions, but not the debate. Therefore, please also register to receive a link for the recording even if you are not able to attend in person.
This work has the patient at the centre and our debate this time will look at What are the issues with POCT/DTCT for patient safety? We want to use this webinar as an opportunity to discuss issues related to POCT and patient safety. We encourage you to give examples of where patients have been impacted. Please include this via the comments in the registration process (see QR code).
Please book by midnight Friday 6th November 2026 to secure your place! Spaces are limited.
Programme
POCT Governance Framework and Toolkit
Clinical Impact
DTCT (Direct-To-Consumer-Testing)
Angela Douglas (BIVDA) • David Gaze (LabMed) • Martin Myers (GIRFT) • Annette Thomas (Former National POCT Clinical Lead, Wales) • David Wells (IBMS)
What are the issues with POCT/DTCT for patient safety?
Evidence from the real world
POCT: how to do it, pitfalls, barriers and successes